Unknown

Dataset Information

0

Selective neuroimmune modulation by type I interferon drives neuropathology and neurologic dysfunction following traumatic brain injury.


ABSTRACT: Accumulating evidence suggests that type I interferon (IFN-I) signaling is a key contributor to immune cell-mediated neuropathology in neurodegenerative diseases. Recently, we demonstrated a robust upregulation of type I interferon-stimulated genes in microglia and astrocytes following experimental traumatic brain injury (TBI). The specific molecular and cellular mechanisms by which IFN-I signaling impacts the neuroimmune response and neuropathology following TBI remains unknown. Using the lateral fluid percussion injury model (FPI) in adult male mice, we demonstrated that IFN α/β receptor (IFNAR) deficiency resulted in selective and sustained blockade of type I interferon-stimulated genes following TBI as well as decreased microgliosis and monocyte infiltration. Molecular alteration of reactive microglia also occurred with diminished expression of genes needed for MHC class I antigen processing and presentation following TBI. This was associated with decreased accumulation of cytotoxic T cells in the brain. The IFNAR-dependent modulation of the neuroimmune response was accompanied by protection from secondary neuronal death, white matter disruption, and neurobehavioral dysfunction. These data support further efforts to leverage the IFN-I pathway for novel, targeted therapy of TBI.

SUBMITTER: Todd BP 

PROVIDER: S-EPMC10436463 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Selective neuroimmune modulation by type I interferon drives neuropathology and neurologic dysfunction following traumatic brain injury.

Todd Brittany P BP   Luo Zili Z   Gilkes Noah N   Chimenti Michael S MS   Peterson Zeru Z   Mix Madison R MR   Harty John T JT   Nickl-Jockschat Thomas T   Ferguson Polly J PJ   Bassuk Alexander G AG   Newell Elizabeth A EA  

Acta neuropathologica communications 20230818 1


Accumulating evidence suggests that type I interferon (IFN-I) signaling is a key contributor to immune cell-mediated neuropathology in neurodegenerative diseases. Recently, we demonstrated a robust upregulation of type I interferon-stimulated genes in microglia and astrocytes following experimental traumatic brain injury (TBI). The specific molecular and cellular mechanisms by which IFN-I signaling impacts the neuroimmune response and neuropathology following TBI remains unknown. Using the later  ...[more]

Similar Datasets

| S-EPMC8686690 | biostudies-literature
| S-EPMC10212211 | biostudies-literature
| S-EPMC5446124 | biostudies-literature
| S-EPMC9945325 | biostudies-literature
| S-EPMC3458163 | biostudies-literature
| S-EPMC5524354 | biostudies-other
| S-EPMC6928557 | biostudies-literature
| S-EPMC6908477 | biostudies-literature
| S-EPMC11424477 | biostudies-literature
| S-EPMC7033501 | biostudies-literature